ULTRACARBON TABLETS 250MG

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

CHARCOAL, ACTIVATED

Boleh didapati daripada:

PROCTER & GAMBLE (MALAYSIA ) SDN.BHD.

INN (Nama Antarabangsa):

CHARCOAL, ACTIVATED

Unit dalam pakej:

20Tablet Tablets; 50Tablet Tablets

Dikeluarkan oleh:

Merck Healthcare KGaA

Ciri produk

ULTRACARBON
®
TABLETS
Information leaflet
Active ingredient: medicinal charcoal
tba
tba/MYS/SGP
COMPOSITION
One tablet contains 250 mg of medicinal charcoal
(Black, round tablets, flat on both sides)
EXCIPIENTS
Bentonite, corn starch.
INDICATIONS
- Acute diarrhoea
- Prevention of absorption in oral intoxications
- Acceleration of elimination in intoxication with
substances subject to enterohepatic circulation
(eg. Carbamazepine, phenobarbital, phenylbuta-
zone, theophylline)
- Symptomatic treatment of flatulence.
CONTRAINDICATIONS
Febrile diarrhoea.
PRECAUTIONS FOR USE
Several poisons and drugs require different or
additional measures.
MEDICINAL CHARCOAL IS NOT EFFECTIVE IN INTOXI-
CATIONS
WITH ORGANIC AND INORGANIC SALTS AS
WELL AS SOLVENTS LIKE, FOR INSTANCE, LITHIUM,
THALLIUM, CYANIDE, IRON SALTS, METHANOL,
ETHANOL AND ETHYLENE GLYCOL.
Different measures are in these cases indicated to
eliminate the poison (e.g. gastric lavage). The
following table lists important poisons in which
medicinal charcoal is ineffective and for which a
suitable oral therapy is known:
In many intoxications, a specific antidote must be
administered additionally to medicinal charcoal
(e.g.acetylcysteine in paracetamol poisoning).
TO AVOID ASPIRATION IN UNCONSCIOUS PATIENTS,
A DOCTOR SHOULD ADMINISTER THESE PATIENTS THE
SUSPENSION OF ULTRACARBON IN WATER BY GASTRIC
TUBE.
IN PATIENTS UNDERGOING MULTIPLE DOSE ACTIVATED
CHARCOAL THERAPY AFTER INTOXICATION, GASTROIN-
TESTINAL SOUNDS SHOULD BE MONITORED FREQUENT-
LY TO ASSESS PERISTALTIC ACTION.
MEDICINAL CHARCOAL SHOULD NOT BE TAKEN IN THE
CASE OF INTOXICATION WITH CORROSIVE SUBSTANCES
(STRONG ACIDS AND ALKALIS) AS THIS WOULD COMPLI-
CATE
DIAGNOSTIC MEASURES like oesophagoscopy
and gastroscopy.
INTERACTIONS
Ultracarbon should not be administered together
with other drugs as the efficacy of the latter may
be reduced.
FERTILITY, PREGNANCY AND LACTATION
No restrictions.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Ultracarbon has no influence on the ability to
drive and use machines.
DOSAGE,